(NASDAQ: AZTA) Azenta's forecast annual revenue growth rate of 2.76% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.6%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.92%.
Azenta's revenue in 2025 is $604,933,000.On average, 3 Wall Street analysts forecast AZTA's revenue for 2025 to be $27,247,134,323, with the lowest AZTA revenue forecast at $27,137,118,976, and the highest AZTA revenue forecast at $27,393,821,453. On average, 3 Wall Street analysts forecast AZTA's revenue for 2026 to be $28,521,478,762, with the lowest AZTA revenue forecast at $27,806,379,005, and the highest AZTA revenue forecast at $29,034,883,715.
In 2027, AZTA is forecast to generate $30,271,639,577 in revenue, with the lowest revenue forecast at $30,271,639,577 and the highest revenue forecast at $30,271,639,577.